Santos GarcĂa, D.; Labandeira Guerra, C.; Yáñez Baña, R.; Cimas Hernando, M.I.; Cabo LĂłpez, I.; Paz Gonález, J.M.; Alonso Losada, M.G.; González Palmás, M.J.; MartĂnez MirĂł, C.
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study. Brain Sci. 2021, 11, 316.
https://doi.org/10.3390/brainsci11030316
AMA Style
Santos GarcĂa D, Labandeira Guerra C, Yáñez Baña R, Cimas Hernando MI, Cabo LĂłpez I, Paz Gonález JM, Alonso Losada MG, González Palmás MJ, MartĂnez MirĂł C.
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study. Brain Sciences. 2021; 11(3):316.
https://doi.org/10.3390/brainsci11030316
Chicago/Turabian Style
Santos GarcĂa, Diego, Carmen Labandeira Guerra, Rosa Yáñez Baña, Maria IcĂar Cimas Hernando, Iria Cabo LĂłpez, Jose Manuel Paz Gonález, Maria Gemma Alonso Losada, MarĂa JosĂ© González Palmás, and Cristina MartĂnez MirĂł.
2021. "Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study" Brain Sciences 11, no. 3: 316.
https://doi.org/10.3390/brainsci11030316
APA Style
Santos GarcĂa, D., Labandeira Guerra, C., Yáñez Baña, R., Cimas Hernando, M. I., Cabo LĂłpez, I., Paz Gonález, J. M., Alonso Losada, M. G., González Palmás, M. J., & MartĂnez MirĂł, C.
(2021). Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study. Brain Sciences, 11(3), 316.
https://doi.org/10.3390/brainsci11030316